The American Lung Association has announced the awarding of eight research grants to researchers in New York City. These grants aim to support studies on significant health issues such as asthma, tuberculosis, pulmonary fibrosis, COPD, respiratory viruses, COVID-19, and lung cancer. The recipients are affiliated with prominent institutions including Icahn School of Medicine at Mount Sinai, Columbia University, Weill Medical College of Cornell University, and Memorial Sloan Kettering Cancer Center.
Over the past year, the American Lung Association Research Institute committed $22 million to research efforts nationwide. This makes it one of the leading programs dedicated to lung health in the United States. The funding supported 139 research projects and included collaborations like the Airways Clinical Research Centers (ACRC) aimed at improving diagnosis and treatment of lung diseases.
Emily Amitin, Director of Development at the Lung Association in New York stated: “In 2024, the American Lung Association is celebrating 120 years of funding lifesaving research. Lung Association researchers have achieved major milestones, including helping end the devastation of tuberculosis in this country, saving millions of lives of premature babies with respiratory distress syndrome (RDS), supporting research on lung cancer, COVID-19 and much more.” She added that lung research is crucial for New York where "2.88 million residents are living with lung disease."
The grant categories include several awards such as the American Lung Association/AAAAI Allergic Respiratory Diseases Award and the Emerging Respiratory Diseases Award among others. These awards cover various aspects related to lung disease.
Research projects funded by these grants undergo a stringent scientific peer review process ensuring they address complex issues within lung health.
Applications for the 2025-2026 research awards cycle are now open. More information about these opportunities can be found on their website Lung.org/awards.
